Choosing the right surgical treatment for hyperopia

Grzeszkowiak, Jan; Wierzbowska, Joanna

doi:10.24292/01.ot.120622

Cited by 1 publication

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1, Jan. 18, 2024 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com of hyperopia is more complex than myopia, and researchers have investigated various refractive procedures for treating hyperopia; however, each of these techniques has drawbacks and cannot be used in all patients [99][100][101][102][103] . Regarding the limitations and challenges of LASIK surgery for hyperopic and presbyopic patients [104][105][106][107] , researchers have been interested in the possibility of using SMILE-extracted lenticules to treat presbyopia and hyperopia [108][109] . Hyperopia treatment Wu et al [110] compared the outcomes of two different surgical methods including SMILE-extracted lenticule implantation (transepithelial phototherapeutic keratectomy and femtosecond laser-assisted lenticule intrastromal keratoplasty (FS-LASIK) for correcting hyperopia ranging from +3.00 to +10.00 D. The results showed a significant increase in uncorrected distance visual acuity with no loss of one or more lines of CDVA.…”

Section: Smile-extracted Lenticules In Ophthalmologymentioning

confidence: 99%

Applications of SMILE-extracted lenticules in ophthalmology

Aghamollaei,

Fallahtafti,

Daryabari

et al. 2024

Int J Ophthalmol

View full text Add to dashboard Cite

AIM: To review recent innovations, challenges, and applications of small incision lenticule extraction (SMILE) extracted lenticule for treating ocular disorders. METHODS: A literature review was performed in the PubMed database, which was last updated on 30 December 2021. There was no limit regarding language. The authors evaluated the reference lists of the collected papers to find any relevant research. RESULTS: Due to the simplicity and accuracy of modern femtosecond lasers and the extensive development of SMILE surgery, many healthy human corneal stromal lenticules were extracted during surgery, motivating some professionals to investigate the SMILE lenticule reusability in different ocular disorders. In addition, new approaches had been developed to preserve, modify, and bioengineer the corneal stroma, leading to the optimal use of discarded byproducts such as lenticules from SMILE surgery. The lenticules can be effectively re-implanted into the autologous or allogenic corneas of human subjects to treat refractive errors, corneal ectasia, and corneal perforation and serve as a patch graft for glaucoma drainage devices with better cosmetic outcomes. CONCLUSION: SMILE-extracted lenticules could be a viable alternative to human donor corneal tissue.

show abstract